Molindone hydrochloride treatment of hospitalized children with conduct disorder

Area of Science:

• Child and Adolescent Psychiatry
• Neuropharmacology
• Pediatric Behavioral Health

Background:

• Aggressive behaviors in hospitalized children require effective pharmacological interventions.
• Molindone and thioridazine are antipsychotic medications used in pediatric populations.
• Assessing treatment-emergent symptoms and behavioral changes is crucial for evaluating drug safety and efficacy.

Purpose of the Study:

• To compare the efficacy and safety of molindone versus thioridazine in aggressive hospitalized children.
• To evaluate treatment-emergent symptoms and behavioral changes associated with molindone and thioridazine.
• To assess the safety profile of molindone in child and adolescent inpatients.

Main Methods:

• An 8-week double-blind study was conducted with 31 aggressive hospitalized children (ages 6-11).
• Participants were randomly assigned to receive either molindone or thioridazine.
• Clinical records of 6 adolescent inpatients treated with molindone were reviewed for comparison.

Main Results:

• Molindone demonstrated comparable efficacy to thioridazine in reducing aggression in the studied pediatric sample.
• Adverse effects showed nonsignificant differences between the two groups.
• Thioridazine treatment was associated with a higher incidence of sedation compared to molindone.

Conclusions:

• Molindone is a potentially safe neuroleptic for child and adolescent inpatients due to its favorable pharmacokinetic profile (short half-life, minimal accumulation).
• Molindone offers an effective alternative to thioridazine for managing aggression in this population.
• Further research is needed to establish definitive indications for molindone in diverse pediatric populations.